Approach to the Patient with Drug Allergy

Medical Clinics of North America

Volumn 94, Issue 4, 2010, Pages 665-679

  Schnyder, Benno ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diagnosis; Drug allergy; Immediate hypersensitivity; Nonimmediate type hypersensitivity; Pseudoallergy; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALLOPURINOL; AMINOPHENAZONE; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CHLORHEXIDINE; CONTRAST MEDIUM; CYCLOSPORIN; DAPSONE; DIPYRONE; DIURETIC AGENT; HEPARIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LAMOTRIGINE; MACROLIDE; METHYLDOPA; MINOCYCLINE; NEUROMUSCULAR BLOCKING AGENT; NEVIRAPINE; PHENYTOIN; PLASMA SUBSTITUTE; PYRAZOLONE; QUININE; QUINOLONE; SALAZOSULFAPYRIDINE; SULFONAMIDE; TRAMADOL; UNINDEXED DRUG;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; CYTOPENIA; DESENSITIZATION; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; EOSINOPHILIA; ERYTHEMA; HEART ARREST; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; LEUKOPENIA; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALAISE; MULTIPLE ORGAN FAILURE; NEPHRITIS; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; SENSITIZATION; SERUM SICKNESS; SKIN TEST; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ADRENAL CORTEX HORMONES; BETA-LACTAMS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; PRESCRIPTION DRUGS; RISK FACTORS; SKIN TESTS; SULFONAMIDES;

EID: 77953549920     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.03.006     Document Type: Review

References (44)

1. Gomes E.R., and Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5 (2005) 309-316
2. Greenberger P.A. 8. Drug allergy. J Allergy Clin Immunol 117 2 Suppl (2006) 464-470
3. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
4. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 137 (2001) 765-770
5. Weiss M.E., and Adkinson N.F. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 107 (1987) 204-215
6. El-Shanawany T., Williams P.E., and Jolles S. Clinical immunology review series: an approach to the patient with anaphylaxis. Clin Exp Immunol 153 (2008) 1-9
7. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 (2002) 240-262
8. Ellis A.K., and Day J.H. Diagnosis and management of anaphylaxis. CMAJ 169 (2003) 307-311
9. Chung C.H., Mirakhur B., Chan E., et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358 11 (2008) 1109-1117
10. Mertes P.M., and Laxenaire M.C. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 4 (2004) 7-16
11. Harboe T., Johansson S.G., Florvaag E., et al. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 62 12 (2007) 1445-1450
12. Brockow K., Romano A., Aberer W., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 64 (2009) 234-241
13. Kvedariene V., Martins P., Rouanet L., et al. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period. Clin Exp Allergy 36 8 (2006) 1072-1077
14. Knowles S.R., Shapiro L.E., and Shear N.H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21 (1999) 489-501
15. Peyrière H., Dereure O., Breton H., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 155 2 (2006) 422-428
16. Shiohara T., Inaoka M., and Kano Y. Drug induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesvirus and antiviral and antidrug immune responses. Allergol Int 55 1 (2006) 1-8
17. Spanou Z., Keller M., Britschgi M., et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 17 10 (2006) 2919-2927
18. Sarzi-Puttini P., Atzeni F., Capsoni F., et al. Drug-induced lupus erythematosus. Autoimmunity 38 7 (2005) 507-518
19. Doyle M.K., and Cuellar M.L. Drug-induced vasculitis. Expert Opin Drug Saf 2 (2003) 401-409
20. Chung W.H., Hung S.I., and Chen Y.T. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7 4 (2007) 317-323
21. Ebo D.G., Fisher M.M., Hagendorens M.M., et al. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 62 (2007) 471-487
22. Pruss A., Salama A., Ahrens N., et al. Immune hemolysis-serological and clinical aspects. Clin Exp Med 3 2 (2003) 55-64
23. Bircher A.J. Symptoms and danger signs in acute drug hypersensitivity. Toxicology 209 (2005) 201-207
24. Evans C., and Tippins E. Emergency treatment of anaphylaxis. Accid Emerg Nurs 13 4 (2005) 232-237
25. Ewan P.W. Anaphylaxis. BMJ 316 (1998) 1442-1445
26. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8 (2002) 5
27. Mennicke M., Zawodniak A., Keller M., et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 9 9 (2009) 2197-2202
28. Empedrad R., Darter A.L., Earl H.S., et al. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 112 (2003) 629-630
29. Mertes P.M., Laxenaire M.C., Lienhart A., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15 2 (2005) 91-101
30. Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 29 (2009) 517-535
31. Brockow K., and Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des 14 27 (2008) 2778-2791
32. Sanz M.L., Gamboa P.M., Garcia-Aviles C., et al. Drug hypersensitivities: which room for biological tests?. Eur Ann Allery Clin Immunol 37 (2005) 230-235
33. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62 10 (2007) 1111-1118
34. Kano Y., Hirahara K., Mitsuyama Y., et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62 (2007) 1439-1444
35. Aberer W., and Kränke B. Provocation tests in drug hypersensitivity. Immunol Allergy Clin North Am 29 (2009) 567-584
36. Demoly P., Romano A., Botelho C., et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 65 (2010) 327-332
37. Pichichero M.E. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 57 (2007) 13-18
38. Frumin J., and Gallagher J.C. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?. Ann Pharmacother 43 (2009) 304-315
39. Mauri-Hellweg D., Zann M., Frei E., et al. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol 157 (1996) 1071-1079
40. Brackett C.C. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 24 7 (2004) 856-870
41. Strom B.L., Schinnar R., Apter A.J., et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 349 (2003) 1628-1635
42. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 6 (2006) 476-481
43. Solensky R. Drug desensitization. Immunol Allergy Clin North Am 24 (2004) 425-443
44. Stevenson D.D. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am 24 3 (2004) 491-505